This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Eosinophilia (drug induced)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • drugs that may cause raised eosinophil count include (1,2,3,4):

    • antimicrobials
      • such as penicillins, cephalosporins, nitrofurantoin, tetracyclines, daptomycin, fluoroquinolones

    • sulphonamides
      • such as sulfasalazine, septrin, dapsone

    • ranitidine

    • allopurinol

    • angiotensin converting enzyme (ACE) inhibitors

    • anticonvulsants
      • such as phenytoin, carbamazepine, lamotrigine

    • antiretrovirals
      • nevirapine, abacavir

    • non-steroidal anti-inflammatory drugs (NSAIDs)

    • methotrexate

    • interleukin-2 (IL-2)

Factors such as intercurrent steroid treatment and bacterial or viral infection can transiently lower eosinophil counts (4)

Reference:

  • Felig P et al (2001) Endocrinology and Metabolism. McGraw-Hill.
  • Hart FD (Ed) (2005). French's Index of Differential Diagnosis.
  • NHS Camden CCG. Abnormal FBC guidance - for adults (Accessed 30/10/19)
  • Thakker C, Booth H L, Lambert J, Morgan S, Checkley A M. Investigating eosinophilia BMJ 2023; 380 :e070295 doi:10.1136/bmj-2022-070295

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.